Transcranial photobiomodulation prevents anxiety and depression <i>via</i> changing serotonin and nitric oxide levels in brain of depression model mice: A study of three different doses of 810 nm laser

  • Emad Eshaghi
    Neurosciences Research Center (NSRC) Tabriz University of Medical Sciences Tabriz Iran
  • Saeed Sadigh‐Eteghad
    Neurosciences Research Center (NSRC) Tabriz University of Medical Sciences Tabriz Iran
  • Gisou Mohaddes
    Neurosciences Research Center (NSRC) Tabriz University of Medical Sciences Tabriz Iran
  • Seyed Hossein Rasta
    Neurosciences Research Center (NSRC) Tabriz University of Medical Sciences Tabriz Iran

抄録

<jats:sec><jats:title>Objectives</jats:title><jats:p>The effectiveness of transcranial photobiomodulation (TPBM) in treating anxiety and depression disorders is a demonstrated and identified issue. However, the optimum therapeutic dose and the underlying mechanism of action are not fully understood. In this study, the therapeutic effects of three different near‐infrared (NIR) doses on anxiety‐ and depression‐like behaviors as well as cerebral levels of serotonin (5‐HT) and nitric oxide (NO) were evaluated in a mouse model of chronic restraint stress (CRS).</jats:p></jats:sec><jats:sec><jats:title>Materials and Methods</jats:title><jats:p>CRS procedure (3 hours/day, over 3 weeks) was performed as a typical stress model to study anxiety and depression along with laser treatment (3 times/week, over 3 weeks), which began simultaneously with CRS. A NIR diode laser (810 nm wavelength, 10 Hz) with the output power of 200 mW and power density of 4.75 W/cm<jats:sup>2</jats:sup> was implemented to deliver three different doses of 4, 8, and 16 J/cm<jats:sup>2</jats:sup> to the cerebral cortex of mice. Behavioral experiments including open field, tail suspension, and elevated plus maze tests as well as serum cortisol levels were assessed to evaluate the anti‐anxiety and anti‐depressive effects of NIR TPBM. The changes of 5‐HT and NO levels in the prefrontal cortex (PFC) and hippocampus (Hipp) were assessed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>CRS procedure induced anxiety‐ and depression‐like behaviors, increased serum cortisol levels, decreased 5‐HT and increased NO levels in the PFC and Hipp areas. NIR TPBM improved behavioral results, decreased serum cortisol levels, increased 5‐HT and decreased NO concentrations in the PFC and Hipp. A dose of 8 J/cm<jats:sup>2</jats:sup> of NIR TPBM showed the maximum effects on behavioral and molecular results, while a decline was observed from the optimum effects at both lower (4 J/cm<jats:sup>2</jats:sup>) and higher (16 J/cm<jats:sup>2</jats:sup>) doses.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our results demonstrated that NIR TPBM had an anti‐anxiety and anti‐depressive effect in CRS mice, which is probably linked to increasing 5‐HT and decreasing NO levels in the PFC and Hipp areas. Also, the maximum anti‐anxiety and anti‐depressive effect was produced at dose of 8 J/cm<jats:sup>2</jats:sup>. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.</jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ